Nuveen Asset Management, LLC Novavax Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 266,638 shares of NVAX stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266,638

Previous 266,638 -0.0%

Holding current value

$3.17 Million

Previous $1.28 Million 0.39%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $24,364 - $38,932	5,076 Added 1.94%	266,638 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $68,808 - $98,412	10,104 Added 4.02%	261,562 $1.89 Million
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $342,257 - $488,499	-51,313 Reduced 16.95%	251,458 $1.87 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $253,301 - $548,820	43,976 Added 16.99%	302,771 $2.1 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $802,928 - $2.27 Million	90,624 Added 53.89%	258,795 $2.66 Million

Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $116,953 - $489,147	-6,426 Reduced 3.68%	168,171 $3.06 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $712,756 - $1.48 Million	-19,646 Reduced 10.11%	174,597 $8.98 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $4.51 Million - $9.24 Million	-64,653 Reduced 24.97%	194,243 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $26.1 Million - $42.3 Million	-193,884 Reduced 42.82%	258,896 $37 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $7.89 Million - $12 Million	44,391 Added 10.87%	452,780 $93.9 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $10.2 Million - $21.8 Million	-84,568 Reduced 17.16%	408,389 $86.7 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $887,796 - $2.51 Million	7,858 Added 1.62%	492,957 $89.4 Million
Q4 2020 May 17, 2021	SELL	$78.74 - $139.5 $799,840 - $1.42 Million	-10,158 Reduced 2.05%	485,099 $54.1 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $132,598 - $234,918	-1,684 Reduced 0.34%	495,257 $55.2 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $862,082 - $1.94 Million	10,852 Added 2.23%	496,941 $53.8 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $4.11 Million - $24.8 Million	296,579 Added 156.5%	486,089 $40.5 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $422,541 - $1.72 Million	107,517 Added 131.13%	189,510 $2.57 Million
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $54,427 - $76,995	-14,750 Reduced 15.25%	81,993 $326,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $36,686 - $71,547	9,126 Added 10.42%	96,743 $486,000
Q2 2019 Aug 15, 2019	BUY	$4.93 - $12.2 $431,951 - $1.07 Million	87,617 New	87,617 $513,000

Others Institutions Holding NVAX

# of Institutions

243

Shares Held

76.1M

Call Options Held

5.06M

Put Options Held

7.19M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $931M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Novavax Inc Transaction History